
Enzymes that unlock the bioactives nature keeps scarce
AI-designed enzymes turn abundant natural substrates into scarce bioactives — peptides, prebiotics, focus compounds — at commercial scale.
Read More

AI-designed enzymes turn abundant natural substrates into scarce bioactives — peptides, prebiotics, focus compounds — at commercial scale.
Read More
Clean labels without trade-offs: how Arzeda-designed enzymes replace synthetic additives with bio-identical ingredients and resilient supply.
Read More
We've just announced that MANE — one of the world's leading flavor and fragrance houses, family-owned, more than 150 years old, with production in 41 countries — has exclusively licensed our ViaLeaf™ Reb M for the purposes of global commercialization.
Read More
Alexandre Zanghellini reflects on Arzeda's mission, the watershed moment computational protein design is having, and what the next chapter looks like for our partners and our team.
Read More